Literature DB >> 8971698

Mitochondrial abnormalities in CLN2 and CLN3 forms of Batten disease.

G Dawson1, J Kilkus, A N Siakotos, I Singh.   

Abstract

The storage of subunit c of mitochondrial ATP synthase, other hydrophobic peptides, and autofluorescent pigment in both late infantile (CLN2) and juvenile (CLN3) neuronal ceroid lipofuscinosis, but not in infantile (CLN1), has raised the question of abnormal mitochondrial function. We now report a partial deficiency in three types of fatty acid oxidation in intact skin fibroblasts from CLN2 and CLN3 patients, but not CLN1. We observed a statistically significant 33% reduction in palmitate (beta-oxidation; mainly mitochondrial) and lignocerate (beta-oxidation; mainly peroxisomal), and a 50% reduction in phytanic acid (alpha-oxidation; mainly peroxisomal) in the absence of exogenous carnitine. In contrast, when we measured fatty acid beta-oxidation (lignoceric acid and palmitic acid), in the same human skin fibroblasts, following lysis in the presence of carnitine, we found no difference in enzyme activity among normal, CLN1, CLN2, and CLN3. However, we did observe a 40% reduction in peroxisomal particulate (bound) catalase activity in CLN1 and CLN2 fibroblasts, which typically results from organellar lipid accumulation or a membrane abnormality. However, total catalase levels were normal, and Western blot analysis of this and three other major oxidant protective enzymes (Mn-dependent superoxide dismutase [MnSOD], CuZn-dependent superoxide dismutase [CuZnSOD], and glutathione peroxidase) were normal in CLN1, CLN2, and CLN3, as well as in liver from an animal (English Setter dog) model for CLN, which shows similar pathology and subunit c storage. Our data showing differences between CLN1 and forms CLN2 and CLN3 suggest some type of mitochondrial membrane abnormality as the source of the pathology in CLN2 and CLN3.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8971698     DOI: 10.1007/BF02815004

Source DB:  PubMed          Journal:  Mol Chem Neuropathol        ISSN: 1044-7393


  7 in total

1.  Apparent loss and hypertrophy of interneurons in a mouse model of neuronal ceroid lipofuscinosis: evidence for partial response to insulin-like growth factor-1 treatment.

Authors:  J D Cooper; A Messer; A K Feng; J Chua-Couzens; W C Mobley
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

2.  Altered mitochondrial function in canine ceroid-lipofuscinosis.

Authors:  A N Siakotos; P S Blair; J D Savill; M L Katz
Journal:  Neurochem Res       Date:  1998-07       Impact factor: 3.996

3.  In the rat brain acetyl-L-carnitine treatment modulates the expression of genes involved in neuronal ceroid lipofuscinosis.

Authors:  Giovanna Traina; Rodolfo Bernardi; Enrico Cataldo; Monica Macchi; Mauro Durante; Marcello Brunelli
Journal:  Mol Neurobiol       Date:  2008-08-23       Impact factor: 5.590

Review 4.  Quality control gone wrong: mitochondria, lysosomal storage disorders and neurodegeneration.

Authors:  L D Osellame; M R Duchen
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 5.  Warning SINEs: Alu elements, evolution of the human brain, and the spectrum of neurological disease.

Authors:  Peter A Larsen; Kelsie E Hunnicutt; Roxanne J Larsen; Anne D Yoder; Ann M Saunders
Journal:  Chromosome Res       Date:  2018-02-19       Impact factor: 5.239

6.  Global network analysis in Schizosaccharomyces pombe reveals three distinct consequences of the common 1-kb deletion causing juvenile CLN3 disease.

Authors:  Christopher J Minnis; StJohn Townsend; Julia Petschnigg; Elisa Tinelli; Jürg Bähler; Claire Russell; Sara E Mole
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

Review 7.  Cellular models of Batten disease.

Authors:  Christopher J Minnis; Christopher D Thornton; Lorna M FitzPatrick; Tristan R McKay
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-10-23       Impact factor: 5.187

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.